Our specialist legal experts advise on a wide range of healthcare matters including advice and representation in transactions and disputes, advising on health and social care regulation, representation in professional discipline proceedings and defending clinical negligence claims.
We represent doctors, dentists, nurses, pharmacists and optometrists in regulatory proceedings before their professional regulators. Our solicitor advocates appear at substantive and interim hearings on our clients' behalf. We also represent clinicians in fatal accident inquiries in the sheriff court, in disciplinary proceedings before employers and in criminal prosecutions, as well as representing healthcare professionals, private hospitals and insurers in civil claims raised in the sheriff court and the Court of Session.
With specialist experience in the care homes sector we advise on development, funding and refinancing, as well as the provision of regulatory advice in relation to the development and operation of care homes.
We provide advice and support during investigations being undertaken by the Medicines and Healthcare Products Regulatory Agency, as well we on decisions of the Scottish Medicines Consortium.
Having dealt with Brodies LLP on a number of matters, what makes us return to them for health procurement is the exceptional understanding of the specialist segment they are working within and as such, advice relating to our queries or concerns is first class. Not being legal nor procurement law experts means we have to turn to those that are, and they make the complicated legal language easy for everyone to understand, enabling us to digest the information and take the appropriate course of action through an informed process.Legal 500 UK 2024
We regularly advise leading global pharmaceutical and biotechnology companies and major manufacturers of medical devices, food and cosmetics.
Our expert lawyers have advised on high value research collaboration and licensing deals, through to the intellectual property aspects of corporate or joint venture transactions.
Many of our lawyers have in-house experience of pharmaceutical and biotechnology companies so we understand the complex commercial, regulatory and privacy issues faced by those operating in this space. That deep knowledge allows us to take a pragmatic and commercial approach whilst ensuring appropriate mechanisms are implemented to protect valuable IP assets, apportion risk and secure the ownership and licence rights that are needed to exploit research results.
In particular, we have extensive experience of advising on: lifecycle management for medicinal products, maximisation of niche IP rights such as regulatory data protection, orphan drug designation, the negotiation of clinical trial agreements and medicines advertising and promotion; as well as collaboration agreements; consortium agreements; compound in-licensing and out-licensing transactions. In addition we also advise on a wide array of bespoke transactional arrangements.
Healthcare & Life Sciences key highlights
- We act as Scottish advisers to the Professional Standards Authority.
- We act for several Scotland’s leading universities on a broad range of complex contractual arrangements with a particular focus on research and development and the commercialisation of IP.
- Many of our lawyers have in-house experience of pharmaceutical and biotechnology companies.
A team of very able and focused individuals. The service is outstanding; they are skilled at identifying key issues, diligent in pursuing those (for example by identifying leading experts and instructing expert evidence) and give measured and robust advice to clients about their options.Legal 500 UK 2024
Strong cross-functional teams of experts to deliver on complex transactions – knowledgeable, balancing risks and commercial requirements – responsive and adaptable to emerging issues.Legal 500 UK 2024
The team acts in a very professional way and has a high level of expertise. Their understanding and recognition of commercial challenges is largely unmatched by other firms therefore solutions are found quickly.Legal 500 UK 2024